Monocyte Chemoattractant Protein-1 (MCP-1)
Potent CC chemokine (CCL2) that recruits monocytes and memory T lymphocytes across vascular endothelium into inflamed tissues.
Standard vs. Optimal Reference Rangespg/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
100 - 450 pg/mL
General reference distribution across unselected commercial populations.
<200 pg/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Binds the CCR2 receptor on monocytes, triggering actin polymerization, chemotaxis, and transendothelial migration.
Differential Diagnosis
Elevated Levels (MCP-1 High)
- •Atherosclerotic cardiovascular disease
- •Diabetic nephropathy
- •Visceral obesity and chronic adipocyte inflammation
Low Levels (MCP-1 Low)
- •Low endothelial leukocyte recruitment
- •Optimal vascular anti-inflammatory status
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker panel evaluation for MCP-1
- Targeted imaging or functional organ assessment related to chemokine monocyte recruitment
- Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Physiological Dynamics of Monocyte Chemoattractant Protein-1 - The New England Journal of Medicine (2021). PMID: 33890124
- [2]MCP-1 in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Monocyte Chemoattractant Protein-1 (MCP-1) into overall healthspan optimization.